GLYCOSAMINOGLYCANS HAVING AN AVERAGE MOLECULAR WEIGHT EQUAL TO 2400 D SUITABLE FOR THE TREATMENT OF SENILE DEMENTIA AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE

摘要

The present invention relates to the use of glycosaminoglycans having an average/molecular weight of 2,400 D for the preparation of pharmaceutical compositions suitable for the treatment of senile dementia, in particular for the treatment of Alzheimer's disease or SDAT (Senile Dementia Alzheimer's Type) and of the cerebral neurological lesions from ictus and from traumas.